FDA, schizophrenia
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way. Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors. All other treatments available for schizophrenia target the dopamine receptors.
FDA Approves the First New Schizophrenia Drug in Decades
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other antipsychotics.
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This innovative medication marks a significant
First New Schizophrenia Treatment in Decades a Much-Needed Alternative
"This drug takes the first new approach to schizophrenia treatment in decades," Tiffany Farchione, a top official in the US Food and Drug Administration (FDA), said in a statement Thursday. "This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously been prescribed,
Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer side effects British scientists have hailed the US approval of a new drug for schizophrenia,
FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
FDA Recalls Gluten-Free Cake and Gives Risk Classification
The "mini raspberry lemon coffee cake" was recalled due to potentially containing undeclared wheat flour and walnuts.
FDA introduces changes for mammograms
Organizations and groups continue to raise awareness regarding breast cancer. However, an important update from a federal ...
FDA warns owners not to feed certain lots of food made by Tukwila company to pets
Samples the FDA took from five types pet foods made by Arrow Reliance, headquartered in Tukwila, tested positive for ...
FDA Approves First Nasal Spray Flu Vaccine You Can Give Yourself at Home
The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.
New Hampshire Union Leader7h
Toxic chemicals found in food packaging; FDA under pressure to take action
Evidence is mounting that food packaging and plastic tableware contain toxic chemicals absorbed by humans, a public health ...
ScienceAlert on MSN45m
FDA-Approved Antidepressant Treats Incurable Brain Cancer in Preclinical Trial
A widely available and inexpensive antidepressant drug may soon save lives from an altogether different kind of disease. The ...
The FDA Is Launching New Traceability Rules for Added Food Safety — and Everyone Is Confused
On January 20, 2026, the Food and Drug Administration's (FDA) new traceability rules — dubbed the Food Traceability Final ...